Related Topics News -

     
 Title only   |   Print 
     
中生製藥第二代氟比洛芬貼劑獲批上市

2026-08-06T  
中生製藥TQB3909片新藥上市申請獲受理

2026-08-04T  
中生製藥創新藥TQB2102再獲納入突破性治療藥物名單

2026-08-03T  
中生製藥與Tempo Scan成立戰略合資拓印尼業務

2026-07-27T  
《大行》野村料中生製藥創新藥持續高增長 維持「買入」評級

2026-07-27T  
中生製藥IM-101注射液「PreS1重組融合蛋白」獲國家藥監局批准臨床試驗

2026-07-23T  
《大行》大摩調整中生製藥2026至28年每股盈測 重申「增持」

2026-07-14T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.